NEWPORT BEACH, CA--(NewMediaWire - May 15, 2017) - ADVANTIS
CORPORATION (OTC PINK: ADVT) is launching The Antidote CBD line of
drinks, which include beverages designed for energy, focus, or
relaxation. Advantis is doing a soft launch of the product through
its existing product pipeline, before introducing it to
convenience, healthy and natural food stores throughout the US.
The agreement to distribute this new line of CBD-based beverages
was an easy decision, according to Advantis CEO, Christopher
Swartz. "Cannabis has so many effective uses for the human body, I
just love all these innovative solutions that help with the daily
'human condition,'" Swartz said. "Using CBD to create elixirs for
things like energy, relaxation and pain management, helping the
mind focus... CBD and other extracts are at the cutting edge of the
health and wellness industry, and we are at the forefront by
marketing products like The Antidote." CBD is an extract from the
marijuana plant that studies have shown to have several beneficial
health benefits. CBD extract is legal for distribution and
consumption across the United States. Each serving of the The
Antidote CBD drinks contain 20MG of 'hemp extract.' "I am excited
to begin distribution of this product because creates opportunity
in two ways," Swartz explained. "First, we already have a high
demand for this product from our existing client base; second, and
more importantly, is that this drink allows us to begin creating
relationships with health food and convenience stores throughout
the country. It is an instant expansion of opportunity and will
create another product pipeline for introduction of additional
products to the consumer space. Finally, this is a premium quality
product that we have tasted and tested -- I immediately knew that
we had to market The Antidote."
Advantis has been adding several new products to its lineup this
year. Swartz reiterated that client relationships continue to
expand as the high product quality and attention to customer
service fuels demand for every product Advantis provides or
produces. "This is a targeted strategy," Swartz expanded. "Creating
value with our relationships -- the value of reliable, quality
products and brand recognition. As we expand these win-win
relationships and create new ones, opportunity and the Advantis
reach grows exponentially. We are becoming known in the industry as
the place to go if you want to expand your distribution channels or
create a branding strategy. Growers, distributors and dispensaries
are now beginning to reach out to us, thanks to the marketing
efforts and networking efforts we have made so far." Swartz
concluded by stating that there are more exciting products being
launched in the coming weeks and months. "This is an exciting year
of growth for Advantis, and the snowball is gaining momentum. We
have a few proprietary products we are launching along with
additional partner branded and co-branded products that will grow
the existing product pipeline; and we are now developing the
consumer product pipeline to propel further expansion. I am
seriously excited about the things we are about to introduce... but
that's all I'll say for now."
Links to Advantis websites can be found at advantiscorp.com, theantidotecbd.com, elixicure.com, and amstercan.com
Social Media Instagram Facebook
ABOUT Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of
innovative products that supply the medical, research, and
pharmaceutical industries. The company additionally establishes
domestic and international partnerships with businesses that
develop and sell proprietary pain management, and consumer products
and services. Product lines for consumer health care, music and
entertainment sectors are in development.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward- looking statements. These risks and uncertainties
include, but are not limited to, economic conditions, changes in
the law or regulations, demand for products of the Company, the
effects of competition and other factors that could cause actual
results to differ materially fromthose projected or represented in
the forward looking statements. Forward- looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under eitherAct.
